Advanced Search

Share

English Português

Home Most often read

Hematology, Transfusion and Cell Therapy

Hematology, Transfusion and Cell Therapy

ISSN: 2531-1379

Hematology, Transfusion and Cell Therapy is a quarterly scientific publication of the Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular (ABHH), Associazione Italo-Brasiliana di Ematologia (AIBE), Eurasian Hematology Oncology Group (EHOG), and Sociedade Brasileira de Oncologia Pediátrica (SOBOPE).

Hematology, Transfusion and Cell Therapy publishes original articles, review articles and case reports covering various areas in the field of hematology and hemotherapy. The journal was previously published, until 2016, as Revista Brasileira de Hematologia e Hemoterapia.

ISSN print: 2531-1379
ISSN online: 2531-1387

Published by Elsevier Editora Ltda, Rio de Janeiro, Brazil.

See more

Congresso Brasileiro de Hematologia, Hemoterapia e Terapia Celular. HEMO 2024. List of conference abstracts.

Congresso Brasileiro de Hematologia, Hemoterapia e Terapia Celular. HEMO 2024. List of conference abstracts.

Indexed in:

Scopus, Medline, Directory of Open Access Journals (DOAJ), PubMed Central (PMC), Emerging Sources Citation Index (ESCI), SCImago Journal Rank (SJR), SNIP

See more

Follow us:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2025

See more

Impact factor 2024

1.6

Citescore

CiteScore measures average citations received per document published.

See more

Citescore 2024

2.0

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

See more

SJR 2024

0.360

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

See more

SNIP 2024

0.754

View more metrics

Open Access Option

Journal Information

Most often read

Vol. 47. Issue. 3

1614

Blood storage effect of G6PD on RBC quality

Andrew Evans Cobbinah, Benedict Sackey, Mina Ofosu, Herbert Ekoe Dankluvi, Stephen Opoku, Ampa Davis Frank

Hematol Transfus Cell Ther. 2025;47:103733

1614

Full text access

Share

847

Efficacy, safety and satisfaction of using emicizumab in hemophilia A patients without factor VIII inhibitors: A systematic review

Isabela de Oliveira Araujo, Lucas Fernandes Suassuna, Isabela Lima dos Santos, Daniela de Oliveira Werneck Rodrigues

Hematol Transfus Cell Ther. 2025;47:103849

847

Full text access

Share

764

Hematological ratios and cytokine profiles in heterozygous beta-thalassemia

Ana Carolina Marques Ciceri, Laura Eduarda de Oliveira, Ana Luísa Richter, José Antonio Mainardi de Carvalho, Maylla Rodrigues Lucena, Guilherme Wataru Gomes, Maria Stella Figueiredo, Magnun Nueldo Nunes dos Santos, ... Clóvis Paniz

Hematol Transfus Cell Ther. 2025;47:103845

764

Full text access

Share

760

The impact of pathogen reduction on ABO isoagglutinin titers in apheresis platelets

Mikayel Yeghiazaryan, Yembur Ahmad, Jessie Singer, Vaanush Nazaryan, Craig Fletcher, Yamac Akgun

Hematol Transfus Cell Ther. 2025;47:103840

760

Full text access

Share

668

Incidence of hepatocellular carcinoma in beta thalassemia: a systematic review and meta-analysis

Marcella Adisuhanto, Alver Prasetya, Alius Cahyadi, Amaylia Oehadian

Hematol Transfus Cell Ther. 2025;47:103934

668

Full text access

Share

666

A dream or reality: Consideration of ‘bloodless’ hematopoietic stem cell transplants for Jehovah’s witness patients

Michael MacNeill, Adrienne Fulford, Deanna Caldwell, Uday Deotare

Hematol Transfus Cell Ther. 2025;47:103958

666

Full text access

Share

592

Long-term follow-up results of ruxolitinib as salvage therapy for chronic graft-versus-host disease

Neslihan Mandaci Sanli, Esen Karakuş

Hematol Transfus Cell Ther. 2025;47:103835

592

Full text access

Share

557

Clinical characteristics and outcomes of non-tuberculous mycobacterial pulmonary infections after hematopoietic stem cell transplantation: A retrospective cohort study

Zahia Esber, Hamza Salam, Shefali Godara, Ayman Soubani

Hematol Transfus Cell Ther. 2025;47:103841

557

Full text access

Share

551

Challenges in diagnosing thrombotic thrombocytopenic purpura

Jeremy W. Jacobs, Garrett S. Booth, Brian D. Adkins

Hematol Transfus Cell Ther. 2025;47:103842

551

Full text access

Share

537

Digital polymerase chain reaction enhances analysis of the cKIT D816V mutation in systemic mastocytosis patients: Clinical insights

Alexandre Eiji Kayano, Luan Lima Marchi, Luciana Nardinelli, Evelin Alves Ramos, Eliane Aparecida Rosseto, Vanderson Rocha, Fernanda Salles Seguro, Elvira Deolinda Rodrigues Pereira Velloso

Hematol Transfus Cell Ther. 2025;47:103938

537

Full text access

Share

499

Advanced molecular approaches to thalassemia disorder and the selection of molecular-level diagnostic testing in resource-limited settings

Balaiah Meenakumari, Chandramouleeswari K, Sariga Dhanasekar

Hematol Transfus Cell Ther. 2025;47:103860

499

Full text access

Share

476

Translation, cross-cultural adaptation, and validation of the HCT frailty scale for hematopoietic stem cell transplant candidates: an observational study

Luz Lorca, Barbara Puga Larrain, Ivana Leao Ribeiro, Ivana Gonzalez Valdivia, Angelia Fernández Hermoso, Francisca Bass Maturana, Francisco Canelo Lazcano

Hematol Transfus Cell Ther. 2025;47:103933

476

Full text access

Share

443

Cutaneous T-cell lymphomas may require an exception to the ABHH consensus regarding empiric vancomycin use in febrile neutropenia

Yung Gonzaga, Jose A. Sanches

Hematol Transfus Cell Ther. 2025;47:103844

443

Full text access

Share

399

Multi-cohort gene expression model enhances prognostic stratification in diffuse large B-cell lymphoma

Valbert Oliveira Costa Filho, Felipe Pantoja Mesquita, Erick Figueiredo Saldanha, Pedro Robson Costa Passos, Mariana Macambira Noronha, Silvia Helena Barem Rabenhorst

Hematol Transfus Cell Ther. 2025;47:103847

399

Full text access

Share

341

Closing the gaps: Tackling myeloma inequities in Latin America

Jorge Contreras

Hematol Transfus Cell Ther. 2025;47:103848

341

Full text access

Share

316

Onset of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis triggered by sudden reactivation of asymptomatic latent Epstein-Barr virus infection

Masanari Mizuki, Takuya Terakawa, Yuka Umeki, Hitomi Matsunaga, Yoshiki Matsuoka, Wataru Nakahara, Shogo Matsui, Mako Ikeda, ... Shuji Ueda

Hematol Transfus Cell Ther. 2025;47:103939

316

Full text access

Share

315

Risk factors associated with HIV infection in four large Brazilian blood centers: A multicentric case-control study (2009–2017)

Fernanda Dominique de Souza Gonçalves, Flávia da Costa Silva, Isabel Cristina Gomes Moura, Cesar de Almeida-Neto, Brian Custer, Ester Cerdeira Sabino, Paula Loureiro, Carolina Miranda, ... Tassila Salomon

Hematol Transfus Cell Ther. 2025;47:103863

315

Full text access

Share

315

CAR T cell therapy-related lumbosacral polyradiculopathy with myelitis and stiff person syndrome with response to intravenous immunoglobulin and corticosteroids in a patient with acute lymphoblastic leukemia

Hannah Goulart, Kevin Elmore, Stephen Scelsa, Daniel Park, Alla Keyzner, Uroosa Ibrahim

Hematol Transfus Cell Ther. 2025;47:103932

315

Full text access

Share

310

Influenza A-triggered Bickerstaff brainstem encephalitis successfully treated with therapeutic plasma exchange: A case report

Piotr F. Czempik, Małgorzata Pięta, Tomasz Jaworski, Piotr Liberski

Hematol Transfus Cell Ther. 2025;47:103843

310

Full text access

Share

306

Oral post-surgical complications in patients with hemophilia and von Willebrand disease

Luisa Catarina Porfirio de Sousa, Elanne Cristina Garcia da Costa Félix, Wagner Hespanhol, Raquel dos Santos Pinheiro

Hematol Transfus Cell Ther. 2025;47:103936

306

Full text access

Share

Publish in

Hematology, Transfusion and Cell Therapy

Hematology, Transfusion and Cell Therapy is a member and subscribes the principles of, the Committee on Publication Ethics (COPE)
www.publicationethics.org.

Idiomas

Hematology, Transfusion and Cell Therapy

Home
All contents
Publish your article
About the journal
- Aims and scope
- Editorial Board
Metrics